Recilisib

DB18310ExperimentalSmall molecule

Recilisib: Overview.

Mechanism: Pharmacologically active on RAC-alpha serine/threonine-protein kinase and Phosphatidylinositol 3-kinase
Curator reviewed
Formula / weight: C₁₆H₁₃ClO₄S · 336.79 g/mol (avg)
Also known as: 4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)benzoic acid · Benzoic acid, 4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)-
Code names: ON-01210

Resolves to

Compound

Structure

InChIKeyKBEKQQJUNVQLDZ-MDZDMXLPSA-NSMILESOC(=O)C1=CC=C(\C=C\S(=O)(=O)CC2=CC=C(Cl)C=C2)C=C1

Targets

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Recilisib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.